Massachusetts policy boosts emergency contraceptive access

News
Article

The statewide standing order policy in Massachusetts significantly increased emergency contraceptive fills at pharmacies, with a notable shift from levonorgestrel to ulipristal, according to a recent study.

Massachusetts policy boosts emergency contraceptive access | Image Credit: © WindyNight - © WindyNight - stock.adobe.com.

Massachusetts policy boosts emergency contraceptive access | Image Credit: © WindyNight - © WindyNight - stock.adobe.com.

The statewide standing order policy in Massachusetts led to a significant increase in emergency contraception fills at pharmacies when compared to other states, according to a recent study in JAMA.1

Takeaways

  1. Massachusetts' statewide standing order policy led to a 32% increase in emergency contraceptive fills at pharmacies compared to other states.
  2. The policy resulted in a notable shift from prescription levonorgestrel to ulipristal for emergency contraception.
  3. The standing order allows pharmacists to prescribe both over-the-counter levonorgestrel and prescription-only ulipristal, removing barriers to access.
  4. The study used a quasi-experimental difference-in-differences design to assess changes in emergency contraceptive fills from July 2021 to December 2023.
  5. Before the policy, emergency contraceptive fill rates were similar between Massachusetts and comparison states, but the standing order led to an additional 25.2 fills per 100,000 women in Massachusetts.

Emergency contraception is vital for pregnancy prevention following unprotected sexual intercourse or contraception failure. It can be used several days after contraception failure and still prevent pregnancy by inhibiting ovulation.2

The first oral emergency contraceptive available in the United States was a dose of pills containing the progestin levonorgestrel. Progestin-based emergency contraception is most effective when taken within 72 hours of unprotected sex, with an 81% to 90% reduced risk of pregnancy.2

Ulipristal may also be used as emergency contraception, with availability in the United States since 2010. It is a single-dose pill with efficacy in preventing pregnancy for up to 5 days after unprotected sexual intercourse. Neither progestin-based pills nor ulipristal are linked to severe adverse events.

Many states have implemented restrictions on abortion access, increasing the need for emergency contraceptives. To address this issue, Massachusetts implemented a statewide standing order for emergency contraceptives.1

The standing order allows the prescription of prescription-only ulipristal (Ella) and over-the-counter levonorgestrel (Plan B) from pharmacists. While pharmacists in 27 states are able to prescribe oral contraceptives to their patients, pharmacists must undergo extra training before receiving access.

Since the Massachusetts policy removes barriers related to contraceptive prescription, a study was conducted to evaluate its association with emergency contraceptive fills at retail pharmacies. Participants included women aged 15 to 49 years.1

Changes in emergency contraceptive fills from July 2021 to May 2022 were compared to those from August 2022 to December 2023, as the statewide order was issued in August 2022. All changes were assessed using a quasi-experimental difference-in-differences design.

Monthly-fill rates for emergency contraceptives were reported as the primary outcome of the analysis, while ulipristal and prescribed levonorgestrel were reported as the secondary outcome. Outcomes were reported per 100,000 women.

There were 92,500 emergency contraceptive fills from July 2021 to October 2023 included in the final analysis. Before the standing order was implemented, a slight increase in emergency contraceptive fills rates was observed in Massachusetts vs comparison states. However, overall trends were similar.1

An emergency contraceptive fill rate of 78.5 fills per 100,000 women was reported before the standing order, vs 105.3 fills per 100,000 women after the standing order. This indicated an increase of 26.8 fills per 100,000 women.

In comparison states, the emergency contraceptive fill rate was 45.8 fills per 100,000 women before the statewide standing order policy and 48.4 fills per 100,000 women after. This indicated an additional 25.2 emergency contraceptive fills per 100,000 women in Massachusetts vs comparison states in the adjusted difference-in-differences analysis.1

For ulipristal, there were an additional 31.6 fills per 100,000 women in Massachusetts vs comparison states. However, no significant differences were observed for levonorgestrel prescriptions, at -6.4 fills per 100,000 women.

These results indicated a 32% increase in emergency contraceptive fills at pharmacies in Massachusetts vs comparison states, as well as a shift from prescription levonorgestrel to ulipristal. Investigators concluded, “policies that reduce prescribing barriers may improve access to emergency contraceptives, particularly ulipristal.”1

References

  1. Qato DM, Guadamuz JS, Myerson R. Changes in emergency contraceptive fills after Massachusetts’ statewide standing order. JAMA. 2024. doi:10.1001/jama.2024.11715
  2. Emergency contraception. KFF. August 4, 2022. Accessed June 3, 2024. https://www.kff.org/womens-health-policy/fact-sheet/emergency-contraception/
Recent Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Matthew Zerden, MD
Marci Bowers, MD | Image Credit: Marcibowers.com
Angela Dempsey
Related Content
© 2024 MJH Life Sciences

All rights reserved.